$Cassava Sciences Inc(SAVA)$ SAVA' stock soared more than 18% after the company said another science journal had found no evidence to support charges it had manipulated data in a 2005 publication.
The stock has more than halved since the allegations were first made in August. Then, a law firm representing admitted short sellers submitted a petition that alleges data manipulation in scientific articles authored by SAVA.
Having completed a careful examination of the data, two Journals have cleared of allegations.
"This reinforces my conviction that false and misleading allegations of scientific misconduct being made against us are simply designed to enrich those making them," said Remi Barbier, president, and CEO of SAVA.
SAVA is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease.SAVA was the top trending stock at publication time.
Two Journals Both Prestigious Peer Review quality and both highly rated are now defending SAVA, which has boosted the bulls' spirits. They believe：
The share price will snap back to its 52 wk high (SAVA's low float will make that happen), and we see a much higher valuation.
Shorts are in huge trouble. All their FUD has been refuted, two separate journals stated “no manipulation’! They can’t hold this down much longer.
Makes us wonder if the market maker buddies of the hedgies artificially brought this down so their pals can get out. Insider trading anyone? Mr. SEC, are you complicit or complacent?
The shorts messed with the wrong stock, wrong investors, wrong company. SAVA is immensely de-risked. Stock will catapult to correct this imbalance. Buy and accumulate！
With SAVA's stock rallying on a lot of good news, are you willing to bet on the stock?
精彩评论